Monte Rosa Therapeutics (GLUE)
Nasdaq • GLUE • US61225M1027
ORTEX Data Highlights
ORTEX Data Highlights
As of Nov 3, 2026, ORTEX estimates 38.9% of free float is sold short, 13.9 days to cover, cost to borrow 0.54%.
Market Cap
923m USD | # 5171 in US
Volume
1.29m shares | 16.32m USD
Shares Outstanding
85.31m
Free Float Shares
63.85% | 54.48m
